Skip to main content

Low dose ‘baby aspirin’ may help certain individuals.


​According to The New England Journal of Medicine and the National Cancer Institute, researchers have reported that “baby” aspirin – a low dose of 81 milligrams – taken daily, reduced the reoccurrence of precancerous polyps in the colon of patients by about 40 percent.
 
“These studies, as well as others, do seem to suggest that aspirin and similar anti-inflammatory drugs help reduce the risk of colorectal cancer in certain individuals,” says Angela McGee, M.D., a board-certified Gastroenterology specialist at Kelsey-Seybold.
 
However, aspirin should never be used as a substitute for regular screening tests, she cautions.
“Additionally,” adds Dr. McGee, “aspirin therapy has side effects and drug interactions to consider, so no one should begin this therapy without talking to their personal physician first.”

Colorectal cancer is a leading cause of cancer deaths in the United States. A good percentage of those deaths could be avoided by regular screening tests to detect and remove polyps before they turn into cancer.

Regular screening is recommended for all Americans 50 and older, and earlier if family members have a history of colorectal disease or cancer.
Alternate Text
Angela McGee, MD

​I believe in providing the same personal care and attention to my patients as I would my family members.